col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


81 Results       Page 1

 [1] 
International Union of Crystallography: Acta Crystallographica Section A Foundations and Advances
  original article Date Title Authors   All Authors
1 [GO] 2024―May―10 Biocrystallography as a means of communication with the general public on the coronavirus and the RNA world L. Coudray, A. Gaudry, C. Sauter
2 [GO] 2024―May―10 Structural insights into ribonucleoprotein dissociation by nucleocapsid protein interacting with non-structural protein 3 in SARS-CoV-2 Xincheng Ni, Yinze Han, Renjie Zhou, Yanmei Zhou, Jian Lei
3 [GO] 2024―May―10 Structure-based study of neutralizing antibodies against SARS-CoV-2 Hua Xu, Bo Wang, Xiaodong Su
4 [GO] 2024―May―10 Discovery of inhibitors targeting viral proteases from SARS-CoV-2 Haitao Yang
5 [GO] 2024―May―10 Structural basis of immune recognition of SARS-CoV-2 and variants: implications for pancoronavirus vaccines and therapeutics Ian A. Wilson
6 [GO] 2024―May―10 Characterisation of NiRAN domain of RNA-dependent RNA polymerase of SARS-CoV-2 as a potential drug target and a novel kinase Deepsikha Kar, Abhisek Dwivedi, Sayan Chakraborty, Bichitra K. Biswal
7 [GO] 2024―May―10 Structural landscape of SARS-CoV-2 entry and activation of spike glycoprotein by engaging unique host factors and potential interventions N. Vankadari, M. Sasikala, X. Fang, L. Tian, S. S. Latha, K. Wang, et al. (+4)
8 [GO] 2024―May―10 Cellular activation pathway of bemnifosbuvir (AT-527), a drug candidate against SARS-CoV-2 infections A. Chazot, C. Zimberger, M. Feracci, S. Hernandez, C. Falcou, A. Moussa, et al. (+5)
9 [GO] 2024―May―10 Crystal structure of SARS-CoV-2 main protease in complex with nirmatrelvir Yinkai Duan
10 [GO] 2024―May―10 Structural analysis of SARS-CoV-2 membrane protein Z. Zhang
11 [GO] 2024―May―10 Structural insight into the mechanism of inhibitor Y180 against SARS-CoV-2 omicron main protease R. Zeng, B. X. Quan, J. X. Qiao, K. Wang, J. Lei, S. Y. Yang
12 [GO] 2024―May―10 Structural reports of four flavonoids and ITC binding study of one with SARS-CoV-2 papain-like protease Hemant P. Yennawar, Anna J. Sigmon, Neela H. Yennawar
13 [GO] 2024―May―10 Inhibiting SARS-CoV-2 PLpro Dale Calleja, David Komander
14 [GO] 2024―May―10 Room-temperature structural studies of SARS-CoV-2 protein, NendoU, with an X-ray free-electron laser S. Botha, R. Jernigan, D. Logeswaran, D. Doppler, N. Nagaratnam, M. Sonker, et al. (+23)
15 [GO] 2024―May―10 Structural studies of SARS-CoV-2 proteins and their complexes Andrzej Joachimiak, Jerzy Osipiuk, Mateusz Wilamowski, Natalia Maltseva, Christine Tesar, Changsoo Chang, et al. (+5)
16 [GO] 2024―May―10 A story of SARS-CoV-2 RNA capping Zihe Rao
17 [GO] 2024―May―10 Structural basis of biased T cell recognition of immune-dominant epitope of SARS-CoV-2 spike protein Priyanka Chaurasia, Thi H. O. Nguyen, Louise C. Rowntree, Jennifer A. Juno, Adam K. Wheatley, Stephen J. Kent, et al. (+3)
18 [GO] 2024―May―10 Structural bases for the higher adherence to ACE2 conferred by the SARS-CoV-2 spike Q498Y substitution E. Erausquin, J. López-Sagaseta
19 [GO] 2024―May―10 Structural basis of T cell recognition of SARS-CoV-2 variants Stephanie Gras
20 [GO] 2024―May―10 Science during a pandemic - remote access to neutron diffractometers M. Kirkham, R. Benson, R. Crompton, M. Everett, L. Grace, P. Parker, et al. (+5)
21 [GO] 2023―Sep―26 Structural studies of non-structural protein 15 (Nsp15) endoribonuclease from original SARS-Cov-2 and its variant epsilon for therapeutic intervention Manashi Sonowal, Nirupa Nagaratnam, Dhenugen Logeswaran, Rebecca Jernigen, Raimund Fromme, Petra Fromme
22 [GO] 2023―Sep―26 Understanding preferences for double-stranded RNA cleavage by SARS-Cov-2 enzyme Nsp15 Zoe M. Wright, Kevin John U. Butay, Isha M. Wilson, Geoff A. Mueller, Mario J. Borgnia, Robin E. Stanley
23 [GO] 2023―Sep―26 Structural insights into N-linked glycan remodeling of the SARS-Cov-2 spike protein Suruchi Singh, Yi Liu, Meghan Burke, Benjamin Jennings, Debajit Dey, Balraj Doray, et al. (+2)
24 [GO] 2023―Sep―26 Atomic-level determinants of SARS-Cov-2 spike trafficking during infection and vaccination Debajit Dey, Suruchi Singh, Enya Qing, Yanan He, Yihong Chen, Benjamin Jennings, et al. (+9)
25 [GO] 2023―Mar―17 The coronavirus structural taskforce G. Santoni, A. Thorn
26 [GO] 2023―Mar―17 Inhibitor screening and structural characterization of virulence factors from SARS-CoV-2 S. Chatziefthymiou, M. Kuzikov, S. Afandi, E. Crosas, G. Pompidor, H. Taberman, et al. (+4)
27 [GO] 2023―Mar―17 Fighting the enemy - understanding SARS-CoV-2 and its disease-causing mechanisms J. Esbjörnsson
28 [GO] 2023―Mar―17 Structural characterization of SARS-CoV-2 spike derived peptides presented by the Human Leukocyte Antigen A*29:02 L. Murdolo, S. Swaminathan, C. Szeto, C. Smith, S. Gras
29 [GO] 2023―Mar―17 Structural bases for the higher adherence to ACE2 conferred by the SARS-CoV-2 spike Q498Y substitution E. Erausquin, J. López-Sagaseta
30 [GO] 2022―Sep―15 Molecular mechanisms of COVID-19 Fang Li
31 [GO] 2022―Sep―15 Structure-guided coronavirus vaccine design David Veesler
32 [GO] 2022―Sep―15 The evolutionary arms race between antibody-mediated immunity and SARS-CoV-2 Timothy Bates
33 [GO] 2022―Sep―15 Structural insights into 2′-O ribosyl methylation of mRNA cap by SARS-CoV-2 Yogesh Gupta
34 [GO] 2022―Sep―15 Structure-guided design of biparatopic nanobodies that potently neutralize SARS-CoV-2 and variants Javeed Dhobi, Jiansheng Jiang, Lisa F. Boyd, Bernard Lafont, Allison Zeher, Rick Huang, et al. (+3)
35 [GO] 2022―Sep―15 Creating new inhibitors to SARS-CoV-2 macrodomain using fragments, neutrons and entropy! James Fraser
36 [GO] 2022―Sep―15 Room-temperature X-ray/neutron crystallography to uncover SARS-CoV-2 main protease function and design potent inhibitors Andrey Kovalevsky
37 [GO] 2022―Feb―11 PDBe-KB COVID-19 data portal - supporting rapid coronavirus research Sameer Velankar
38 [GO] 2022―Feb―11 3DBionotes Covid-19 edition José Ramon Macias, Ruben Sanchez-Garcia, Pablo Conesa, Erney Ramirez-Aportela, Marta Martinez Gonzalez, Carlos Wert-Carvajal, et al. (+6)
39 [GO] 2022―Feb―11 The Argentinian Crystal Growing Contest and other educational activities in Argentina during the COVID-19 pandemic Sebastián Klinke, Valeria Cintia Fuertes, Vanina Gisela Franco, Clarisa Ester Alvarez, Diego Germán Lamas
40 [GO] 2022―Feb―11 Crystallography schools and other educational activities in Latin America during the COVID-19 pandemic Diego Germán Lamas
41 [GO] 2022―Feb―11 University remote teaching in crystal chemistry during the COVID-19 pandemic: positive and negative aspects Olga V. Grineva
42 [GO] 2022―Feb―11 Structural basis of mRNA cap modification by SARS-CoV-2: role of metal ions and implications for COVID-19 severity by emerging variants Yogesh K. Gupta, Thiruselvam Viswanathan, Anurag Misra, Siu-Hong Chan, Shan Qi, Shailee Arya, et al. (+2)
43 [GO] 2022―Feb―11 Targeting COVID-19 viral enzymes in an evolving landscape of publishing and peer review James Fraser
44 [GO] 2022―Feb―11 A structure-guided taxonomicbased approach to the design of broad-spectrum coronavirus protease inhibitors Andrew D. Mesecar, Sarah E. St John, Emma K. Lendy, Brandon J. Anson, Mackenzie E. Chapman, Arun K. Ghosh
45 [GO] 2022―Feb―11 The Coronavirus Structural Task Force Andrea Thorn
46 [GO] 2022―Feb―11 Validation of cryo-EM structures of SARS-CoV-2 and mapping genomic mutations Sony Malhotra, Martyn Winn, Agnel Praveen Joseph
47 [GO] 2022―Feb―11 Crystallographic fragment screening of SARS-CoV-2 drug discovery targets Daren Fearon, Alice Douangamath, Ailsa Powell, Alex Dias, Anthony Aimon, Jose Brandao-Neto, et al. (+5)
48 [GO] 2022―Feb―11 Structural studies towards the development of an oral main protease (Mpro) inhibitor to treat SARS-CoV-2 infection Joanne Lemieux, Muhammad Bashir Khan, Jimmy Lu, Elena Arutyunova, James Nieman, D. Lorne Tyrrell, Howard S. Young
49 [GO] 2022―Feb―11 Fragment-based drug discovery of SARS-CoV-2 main protease Weixiao Song, Sen Li, Ah Wing Edith Chan, Alun Coker
50 [GO] 2022―Feb―11 A crystallographic snapshot of SARS-CoV-2 main protease maturation process Gabriela D. Noske, Aline Minali Nakamura, Victor O. Gawriljuk, Rafaela S. Fernandes, Gustavo M. A. Lima, Higor V. D. Rosa, et al. (+6)
51 [GO] 2022―Feb―11 The temperature-dependent conformational ensemble of SARS-CoV-2 main protease (Mpro) Ali Ebrahim, Blake T. Riley, Desigan Kumaran, Babak Andi, Martin R. Fuchs, Sean McSweeney, Daniel A. Keedy
52 [GO] 2022―Feb―11 Co-crystallization of hepatitis C virus NS3/4A inhibitors and SARS-CoV-2 main protease using high-density acoustic droplet ejection (ADE) Babak Andi, Dale F. Kreitler, Desigan Kumaran, Alexei S. Soares, Jantana Keereetaweep, Jean Jakoncic, et al. (+4)
53 [GO] 2022―Feb―11 Structure of SARS-CoV-2 papain-like protease PLpro reveals a framework for antiviral inhibitor design Vasundara Srinivasan, Nadine Werner, Sven Falke, Hévilla Brognaro, Sebastian Günther, Patrick Y. A. Reinke, et al. (+3)
54 [GO] 2022―Feb―11 Transient complexes of the Nsp7, Nsp8 and Nsp12 in SARS-CoV-2 replication transcription complex Greg Hura
55 [GO] 2022―Feb―11 Investigation of furin inhibition to block SARS-CoV-2 spike protein cleavage and structural stability via molecular docking and molecular dynamics simulations Jaganathan Ramakrishnan, Archana Chinnamadhu, Kumaradhas Poomani
56 [GO] 2022―Feb―11 Enhanced peer review - rebuilding early SARS-CoV-2 structures in ISOLDE Tristan Ian Croll
57 [GO] 2022―Feb―11 Structural basis of SARS-CoV-2 translational shutdown and programmed ribosomal frameshifting Nenad Ban
58 [GO] 2022―Feb―11 Neutron crystallography for drug design targeting SARS-CoV-2 viral proteins Andrey Kovalevsky, Daniel Kneller, Leighton Coates
59 [GO] 2022―Feb―11 Integrating a discovery-based remote/hybrid crystallography laboratory module into an undergraduate teaching laboratory during the pandemic Joe Tanski
60 [GO] 2022―Feb―11 The role of structural biology in pandemic's puzzles: amino acids and short peptides as key players Joanna Bojarska, Vasso Apostolopous, John Matsoukas, Jack Feehan, Harry Ridgway, Piotr Zielenkiewicz, Wojciech M. Wolf
61 [GO] 2022―Feb―11 Learning in 3D with Pymol and Proteopedia during a pandemic: enzyme catalysis and conformational change Roderico Acevedo, Karsten W. Theis
62 [GO] 2021―Oct―21 A blended learning approach for a crystallography-based undergraduate practical (under COVID-19 restrictions) Peter Horton, Simon Coles
63 [GO] 2021―Oct―21 SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity Michael Joyce
64 [GO] 2021―Oct―21 Bioinformatics and 3D structural analysis of the coronavirus main protease active site Amy Wu Wu, Mickayla Bacorn, Mary-Agnes Balogun, Cassandra Olivas, Christine Zardecki, Sagar Khare, et al. (+2)
65 [GO] 2021―Oct―21 Biochemical analysis and review of the active site evolution of SARS-CoV-2 and other coronaviruses Mickayla Bacorn
66 [GO] 2021―Oct―21 A global consortium, next-generation SARS-CoV-2 antibody therapeutics and stabilized spike Erica Saphire
67 [GO] 2021―Oct―21 Direct visualization of SARS-CoV-2 main protease electrostatics using neutron crystallography Daniel Kneller, Stephanie Galanie, Gwyndalyn Phillips, Leighton Coates, Andrey Kovalevsky
68 [GO] 2021―Oct―21 Mg2+ and Mn2+ coordinate Cap-0-RNA to position substrates for efficient 2′-O-methyl transfer by SARS-CoV-2 nsp16 Monica R. Lemus, George Minasov, Ludmilla Shuvalova, Nicole L. Inniss, Joseph S. Brunzelle, Courtney M. Daczkowski, et al. (+3)
69 [GO] 2021―Oct―21 Understanding the active site of the SARS-CoV-2 papain-like protease (PLPro) Mary-Agnes Balogun, Amy Wu Wu, Mickayla Bacorn, Cassandra Olivas, Christine Zardecki, Joseph Lubin, et al. (+2)
70 [GO] 2021―Oct―21 Deploying high-throughput protein crystallography-based drug discovery platforms to establish a structure-based drug discovery system for SARS-CoV-2 proteins Debanu Das
71 [GO] 2021―Oct―21 Structures of synthetic nanobodies in complex with SARS-CoV-2 spike or receptor-binding domain provide insights for developing therapeutics and vaccines Jiansheng Jiang, Javeed A. Dhobi, Kannan Natarajan, Lisa F. Boyd, Rick Huang, Allison Zeher, David H. Margulies
72 [GO] 2021―May―11 Mapping COVID-19 mutations in 3D: how SARS-CoV-2 has evolved during the first 6 months of the global pandemic Aaliyah Khan, Christine Zardecki, Stephen Burley, Sagar Khare
73 [GO] 2021―May―11 Delving into COVID-19 'seams': examining the structural fabric of SARS-CoV-2 Luz Alfaro, Christine Zardecki, Sagar Khare, Stephen Burley
74 [GO] 2021―May―11 Structural insights into the feline coronavirus drug GC376, which inhibits the main protease of SARS-CoV-2 and blocks virus replication Joanne Lemieux, Wayne Vuong, Muhammad Bashir Khan, Conrad Fischer, Elena Arutyunova, Tess Lamer, et al. (+8)
75 [GO] 2021―May―11 Structural analysis of severe acute respiratory syndrome coronavirus-2 proteins: exploring mutations in Nsp13 Brea Tinsley, Stephen Burley, Christine Zardecki, Sagar Khare
76 [GO] 2021―May―11 Protein Data Bank in the time of coronavirus: how open-access 3D structures are enabling research and development in fundamental biology, biomedicine, biotechnology and drug discovery as we confront the global SARS-CoV-2 pandemic Stephen Burley
77 [GO] 2021―May―11 Structural basis of recognition of SARS-CoV-2 by neutralizing antibodies isolated from convalescent patients Ian Wilson, Meng Yuan, Nicholas C. Wu, Hejun Liu, Chang-Chun D. Lee, Xueyong Zhu
78 [GO] 2021―May―11 Crowdsourcing inhibitor discovery against the SARS-CoV-2 main protease Nir London
79 [GO] 2021―May―11 Understanding the evolution of SARS-CoV-2 non-structural protein 15 (Nsp15) in three dimensions (3D) Sophia Staggers, Christine Zardecki, Sagar Khare, Stephen Burley
80 [GO] 2021―May―11 Crystallography of SARS-CoV-2 non-structural proteins Andrzej Joachimiak, Changsoo Chang, Michael Endres, Robert Jedrzejczak, Youngchang Kim, Natalia Maltseva, et al. (+6)
81 [GO] 2021―May―11 Structure-based design of prefusion-stabilized SARS-CoV-2 spikes Jason McLellan
 [1] 

81 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec